Page last updated: 2024-08-21

acridines and Agranulocytosis

acridines has been researched along with Agranulocytosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, AP; Grem, JL; Hamilton, JM; Harold, N; Jasser, GB; Kao, V; Keith, B; Monahan, BP; Pace, M; Pang, J; Quinn, MG; Takimoto, CH1
King, GW; Kraut, EH; Kuebler, JP; Moore, T; Triozzi, P1

Trials

2 trial(s) available for acridines and Agranulocytosis

ArticleYear
A phase I pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patients.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:7

    Topics: Acridines; Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Apoptosis; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pyrazoles

2002
Phase II study of pyrazoloacridine in metastatic renal cell carcinoma.
    Investigational new drugs, 2001, Volume: 19, Issue:4

    Topics: Acridines; Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Evaluation; Humans; Kidney Neoplasms; Lung Neoplasms; Middle Aged; Nausea; Pyrazoles; Thrombocytopenia; Vomiting

2001